Free Trial
NASDAQ:CALA

Calithera Biosciences (CALA) Stock Price, News & Analysis

$0.01
0.00 (0.00%)
(As of 07/19/2024 ET)
Today's Range
$0.01
$0.0125
50-Day Range
$0.01
$0.02
52-Week Range
$0.01
$0.13
Volume
491 shs
Average Volume
4,562 shs
Market Capitalization
$48,700.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CALA stock logo

About Calithera Biosciences Stock (NASDAQ:CALA)

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

CALA Stock Price History

CALA Stock News Headlines

[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Arcus Biosciences Inc (RCUS)
Christina Cala
CALA - Calithera Biosciences, Inc.
[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Cala Mariolu
Cala Llombards
Calithera Biosciences to Liquidate >CALA
See More Headlines
Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2021
Today
7/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CALA
Fax
N/A
Employees
8
Year Founded
2010

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.75 million
Book Value
($0.40) per share

Miscellaneous

Free Float
4,550,000
Market Cap
$48,720.00
Optionable
Not Optionable
Beta
-0.18

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Stephanie Wong (Age 50)
    CFO & Secretary
    Comp: $752.42k
  • Dr. Christopher J. Molineaux Ph.D. (Age 71)
    Senior Vice President of Development
    Comp: $405k
  • Mr. Frank Parlati Ph.D. (Age 55)
    Senior Vice President of Research

CALA Stock Analysis - Frequently Asked Questions

How have CALA shares performed this year?

Calithera Biosciences' stock was trading at $0.03 at the beginning of 2024. Since then, CALA stock has decreased by 66.7% and is now trading at $0.01.
View the best growth stocks for 2024 here
.

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) posted its quarterly earnings data on Monday, November, 8th. The biotechnology company reported ($3.00) earnings per share for the quarter, topping the consensus estimate of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter.

When did Calithera Biosciences' stock split?

Shares of Calithera Biosciences reverse split on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX) and Rigel Pharmaceuticals (RIGL).

This page (NASDAQ:CALA) was last updated on 7/20/2024 by MarketBeat.com Staff

From Our Partners